Interim laboratory biosafety guidelines for handling and processing specimens associated with 2019 novel coronavirus (2019-nCoV)

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  To date, we do not fully understand the pathogenic potential and transmission dynamics of 2019 Novel Coronavirus (2019-nCoV). Until more information becomes available, precautions should be taken in collecting and handling specimens that may contain 2019-nCoV. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible 2019-nCoV infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling 2019-nCoV specimens are provided below.
• Subjects:
  Clinical Laboratory Techniques Communicable Diseases, Emerging Containment Of Biohazards Coronavirus Infections COVID-19 Testing Respiratory Tract Infections/diagnosis Safety Specimen Handling
• Series:
  Coronavirus Disease 2019 (COVID-19)
• Document Type:
  Text
• Genre:
  Guideline
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:4cbbd52fc61505af08c164473fce527735c2b8c94cbb0850522b545c7d42ab38c306161e6e1caaf37686bcdceb55600ec6bb8b9542967383c29530562198f8f7
• Download URL:
  https://stacks.cdc.gov/view/cdc/84427/cdc_84427_DS1.pdf
• File Type:
  [PDF - 59.22 KB ]